Drug Eluting Stent Market Overview
Drug eluting stents are vascular prosthesis. Drug eluting stents are coated with slow-releasing medication which helps in preventing blood clots forming in a stent. Drug eluting stents are combination of drug and device components. Blood clot in a stent causes future blockages which may lead to heart attack. Drug eluting stents are used by interventional cardiologists for reopening and maintaining patent coronary arteries which are narrowed by arteriosclerosis. Drug eluting stents shows superior clinical performance as compared to bare metal stents. Drug eluting stents (DES) includes, two bioresorbable polymer DES (SYNERGY and Orsiro), zotarolimus eluting stents (R-ZES), everolimus-eluting stents, and ridaforolimus-eluting stents. Drug eluting stents are widely used in treating blockages of heart arteries. Drug eluting stents has become superior in conventional endovascular treatment used for infrapopliteal peripheral artery disease. Drug eluting stents requires longer duration of dual antiplatelet therapy for minimizing chance of stent thrombosis. Drug eluting stents helps in reducing target vessel revascularization and decrease the risk of cardiovascular mortality and myocardial infarction. When surgeon insert a drug eluting stent the stent release medication directly into artery. The released medication into artery helps in preventing forming of scar tissues within the stent and helps in narrowing blood vessels. After the procedure additional medications like blood thinners should be taken. Drug eluting stents are placed against artery walls which will help in holding it and opened and slowly medication is released directly into artery
Drug Eluting Stent Market Dynamics
Rise in cardiovascular diseases and rate of urbanization
Rise in cardiovascular diseases and rate of urbanization is one of the leading factors for the Global Drug eluting stents Market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affected the health of human being. Urbanization has given rise in disposable income which allows the individual to enhance their lifestyle, consuming high amount of red meat and animal derived food, fats & oils, sugar, sodium, lack of exercise, alcohol intake, which has become the risk factors of heart diseases. Change in lifestyle, consumption of unhealthy food and poor nutrition diet has caused chronic disease like heart disease, diabetes, obesity, overweight, raised blood lipids, high blood pressure, etc. Drug eluting stents in cardiovascular disease is used in treating blockages of heart arteries. Many heart problems are successfully treated by drug eluting stents. Drug eluting stents helps in preventing need for more invasive procedures like coronary artery bypass surgery. For instance in 2020, according to American College of Cardiology, number of people are dying due to cardiovascular disease (CVD) which includes one-third of deaths globally in 2019. Around 6 million of deaths is caused by cardiovascular disease between ages of 30-70. According to American Heart Association’s 2017 Heart Disease and Stroke Statistics Update, number of an individual diagnosed with heart failure is increasing rapidly and projected to rise by 46% till 2030. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in cardiovascular diseases and population in urban areas boosts the demand for Drug eluting stents market.
Technological advancement
Technological advancement has become the major factor in target market growth. Rising adoption of technological advancement in drug eluting stents has helped in reducing duration of the treatment for high-risk conventional surgical patients. Stenting of arteries has become the common treatment of cardiovascular medicine which enables the re-opening of narrowed vessels and helps in restoring normal blood flow. Advancement in technology has provide rapid development of drug eluting stents which has determined to provide good efficacy with lowering rate of treatment failure. New advancement has expanded the stent application to patients with complicated diseases. New drug eluting stents has been developed which helps in minimizing neo-intimal hyperplasia, in reducing repeat revascularization, minimizing stent thrombosis rate and ensuring good acute and long term results.
Restrains:
However, drug eluting stents has given positive impact in treating heart blockages but some side effects of stent are observed like stent may get blood clot where it is placed which causes stroke or heart attack. Side effects like infection, allergic reaction to dye & stent, damage to blood vessel from catheter, coronary artery rupture, closure may somewhat restrain the Drug eluting stents market growth.
Drug Eluting Stent Market Segmentation
Drug Eluting Stent Market is segmented based on coating, application, end-users and region.
Coating Insight
On the basis of Coating Drug Eluting Stent Market is segmented into Polymer-based coatings, Polymer-free coatings, and others.
Application Insights
On the basis of Application Drug Eluting Stent Market is segmented into Peripheral Artery Disease, Coronary Artery Disease, and others. Coronary Artery Disease has dominated the target market due to approval of drug eluting stents in coronary artery disease treatment and rising prevalence of Coronary Artery Disease.
End-Users
On the basis of Distribution Channel Drug Eluting Stent Market is segmented into Hospitals, Ambulatory Surgical Centers, Cardiology Centers, and Specialty Clinics. Cardiology centers has dominated the target market due to rising incidence of cardiovascular diseases.
Regional Insights:
On region the Drug Eluting Stent Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, leading sedentary lifestyle, rising prevalence of heart disease like stroke, heart attack and rising demand is anticipated to increase demand for Drug Eluting Stent in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Coating - Polymer-based coatings, Polymer-free coatings, and others By Application - Peripheral Artery Disease, Coronary Artery Disease, and others By End-Users - Hospitals, Ambulatory Surgical Centers, Cardiology Centers, and Specialty Clinics |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Drug Eluting Stent Market report based on coating, application, end-users and region:
Drug Eluting Stent Market, By Coating:
- Polymer-based coatings
- Polymer-free coatings
- Others
Drug Eluting Stent Market, By Application:
- Peripheral Artery Disease
- Coronary Artery Disease
- Others
Drug Eluting Stent Market, By End-Users:
- Hospitals
- Ambulatory Surgical Centers
- Cardiology Centers
- Specialty Clinics
Drug Eluting Stent Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Drug Eluting Stent Market Key Players
The key players operating the Drug Eluting Stent Market includes,
Abbott
It is the world’s leading drug eluting stents. It also offers diagnostic tools, vascular devices, science-based nutritional products, branded generic pharmaceuticals and others.
Cook Medical
It has expanded broadest range of drug-eluting stents. It offers products and services in burn surgery, colorectal surgery, cardiothoracic surgery and others.
Medtronic
It is the global leader in healthcare technology. It also offers drug eluting stents, surgical products, aortic stent graft products, and others.
Biotronik
It is the global medical device company which offers innovative technologies for endovascular and cardiovascular diseases.
MicroPort Scientific Corporation
It is an international medical device company. It offers drug eluting stents, products for surgical procedures and others.
Boston Scientific Corporation
It offers products like coronary stents, implanted devices, pacemakers, cardiac resynchronization therapy (CRT), and others.
Terumo Corporation
It is the global leader in medical technology and manufacturer, supplier of medical devices.
Meril Life Sciences
It offers wide range of diagnostic instruments like analyzers, reagents, rapid testing kits, medical devices for vascular interventions, etc.
Wellinq
It is the designer and producer of innovative and high quality of drug eluting balloons, coronary stents, catheters, etc.
B. Braun Melsungen AG
It offers coronary drug eluting stents, medical equipment and provides healthcare solutions.
Biosensors International Group Limited
It is the manufacturer of innovative medical devices for interventional cardiology.
Recent Development:
- In August 2022, Medtronic has launched new latest generation drug eluting coronary stent ‘Onyx Frontier’ system following CE Mark recent approval. It offers innovative delivery system. Newly launched drug eluting stent includes increased catheter flexibility, lower crossing profile and innovative dual layer balloon.
- In January 2022, Cook Medical has received FDA breakthrough for designation of new drug eluting stent. This new drug eluting stent is designed for treating patients who are suffering from chronic limb-threatening ischemia (CLTI).
Drug Eluting Stent Market Company Profile
- Medtronic*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Abbott
- Cook Medical*
- Biotronik
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Terumo Corporation
- Meril Life Sciences
- Wellinq
- B. Braun Melsungen AG
- Biosensors International Group Limited
“*” marked represents similar segmentation in other categories in the respective section
Drug Eluting Stent Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Coating
- Market Snippet, By Application
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Drug Eluting Stent Market, By Coating
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Polymer-based coatings
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Polymer-free coatings
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Drug Eluting Stent Market, By Application, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Peripheral Artery Disease
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Coronary Artery Disease
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Drug Eluting Stent Market, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Cardiology Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Specialty Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Drug Eluting Stent Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Coating, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Coating, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Coating, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Coating, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Overview
-
-
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Coating, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
-
-
- GCC
- Rest of Middle East
- South Africa
- Israel
- GCC
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cook Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Biotronik
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- MicroPort Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Terumo Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Meril Life Sciences
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Wellinq
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Biosensors International Group Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Drug Eluting Stent Market is segmented into coating, application, end-users, and region.
Drug Eluting Stent Market is driven by factors like rise in cardiovascular diseases, rate of urbanization, and technological advancement.
By region, the Drug Eluting Stent market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.
The key players operating the Drug Eluting Stent Market includes, Abbott, Cook Medical, Medtronic, Biotronik, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Meril Life Sciences, Wellinq, B. Braun Melsungen AG, Biosensors International Group Limited, and others.